CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myelomaMay 1, 2019Multiple MyelomaHematologic Malignancies
Similar results for once- or twice-weekly carfilzomib in MMFebruary 23, 2019Multiple MyelomaRare Diseases
10 Important VA Studies You Might Have Missed at ASHDecember 14, 2018Multiple MyelomaHematologic Malignancies
P-BCMA-101 gains FDA regenerative medicine designationNovember 9, 2018Multiple MyelomaHematologic Malignancies
What’s the Impact of Osteoporosis in Multiple Myeloma?November 8, 2018Multiple MyelomaHematologic Malignancies
Will quad therapy become the new standard in myeloma?October 2, 2018Multiple MyelomaHematologic Malignancies
STORM trial shows response in penta-refractory myelomaSeptember 16, 2018Multiple MyelomaHematologic MalignanciesOncology
